Concourse Financial Group Securities’s Blueprint Medicines BPMC Stock Holding History

Concourse Financial Group Securities’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	-$194	–	2284
2023 Q3	$150	Hold	3	–	–	﹤0.01%	2259
2023 Q2	$189	Hold	3	–	–	﹤0.01%	2291
2023 Q1	$134	Buy	+3	New	+$135	﹤0.01%	2325
2021 Q1	–	Sell	-25	Closed	-$2.5K	–	2339
2020 Q4	$3K	Buy	+25	New	+$2.63K	﹤0.01%	2016
2019 Q4	–	Sell	-300	Closed	-$22.5K	–	2049
2019 Q3	$22K	Hold	300	–	–	0.01%	923
2019 Q2	$28K	Buy	+300	New	+$24.8K	﹤0.01%	1095

Other funds holding BPMC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Concourse Financial Group Securities's BPMC Position: Q4 2023 in Review

Concourse Financial Group Securities sold out of Blueprint Medicines (BPMC) in Q4 2023, closing a stake of 3 shares — an estimated $194 sold.

Concourse Financial Group Securities first reported a position in BPMC in Q2 2019 and held it in 6 quarters. The position peaked at $28K in Q2 2019. 259 funds tracked by Wall St. Rank hold BPMC as of Q4 2023.

Concourse Financial Group Securities reported no remaining Blueprint Medicines position as of Q4 2023 after selling out during the quarter.
Concourse Financial Group Securities sold 3 Blueprint Medicines shares in Q4 2023, an estimated $194.
Concourse Financial Group Securities first reported a position in Blueprint Medicines in Q2 2019 and held it in 6 quarters.
Concourse Financial Group Securities's Blueprint Medicines position peaked at $28K in Q2 2019.
259 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2023.

Based on Concourse Financial Group Securities's 13F filing for Q4 2023, filed 7 Feb 2024.